Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Class duplication prescriptions in patients taking fixed-dose combination antihypertensives

고혈압 복합제 복용환자에서 동일계열약물 중복 현황

  • Received : 2022.05.31
  • Accepted : 2022.06.23
  • Published : 2022.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Fixed-dose combinations have the advantage of improving patient compliance, but may increase the risk of duplicate prescriptions. As the use of fixed-dose combination antihypertensives increases, it is necessary to investigate the current status of class duplication prescriptions (CDP) in patients taking fixed-dose combination antihypertensives in Korea and to identify factors associated with CDP. Methods: We conducted a retrospective observational study using nationally representative claim data. Hypertensive patients aged 20 years or older taking fixed-dose combination antihypertensives were extracted. Among these patients, patients with CDP were identified. A chi-square test was applied to determine the differences between patients with CDP and non-CDP. The associated factors of CDP were identified through multiple logistic regression. Results: Of the 74,165 patients who were prescribed fixed-dose combination antihypertensives, 426 patients (0.6%) with CDP were identified. The most common antihypertensive class associated with CDP was calcium channel blockers (194 patients, 45.5%), followed by angiotensin II receptor blockers (136 patients, 31.9%). Patients aged 75 years or older (odds ratio [OR] 1.83, 95% confidence interval [CI] 1.02-3.52), chronic kidney disease (OR 4.45, 95% CI 2.15-8.25), chronic heart failure (OR 2.71, 95% CI 1.93-3.72), coronary artery disease (OR 2.22, 95% CI 1.60-3.03) and Medical Aid/Patriots and Veterans Insurance (OR 1.49, 95% CI 1.04-2.07) were significantly associated with increased CDP. Conclusions: The factors associated with CDP were the elderly, comorbidities, and low socioeconomic status. Since CDP can result in negative clinical outcomes, active intervention by the pharmacist is warranted.

Keywords

References

  1. Kang H-Y, Ko S-K, Liew D. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions. Clin Ther 2009;31(12):2919-30. https://doi.org/10.1016/j.clinthera.2009.12.013
  2. Kim HC, Cho SMJ, Lee H, et al. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens 2021;27(1):1-4. https://doi.org/10.1186/s40885-020-00159-7
  3. Lee J-H, Kim K-I, Cho M-C. Current status and therapeutic considerations of hypertension in the elderly. Korean J Intern Med 2019;34(4):687. https://doi.org/10.3904/kjim.2019.196
  4. Youn HM, Lee HJ, Park E-C. Position value for relative comparison of healthcare status of Korea in 2018. Health Policy Manag 2021;31(2): 217-24. https://doi.org/10.4332/KJHPA.2021.31.2.217
  5. Lee H-Y, Shin J, Kim G-H, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens 2019;25(1):1-24. https://doi.org/10.1186/s40885-018-0104-6
  6. Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med 2020;30(3):160-4. https://doi.org/10.1016/j.tcm.2019.05.003
  7. Moriarty F, Bennett K, Fahey T. Fixed-dose combination antihypertensives and risk of medication errors. Heart 2019;105(3):204-9. https://doi.org/10.1136/heartjnl-2018-313492
  8. Gradman AH, Basile JN, Carter BL, Bakris GL; American Society of Hypertension Writing Group. Combination therapy in hypertension. J Am Soc Hypertens 2010;4(2):90-8. https://doi.org/10.1016/j.jash.2010.03.001
  9. Kim SH, Shin DW, Kim S, et al. Prescribing patterns of antihypertensives for treatment-naive patients in South Korea: from Korean NHISS claim data. Int J Hypertens 2019;2019:4735876.
  10. Takahashi Y, Ishizaki T, Nakayama T, Kawachi I. Social network analysis of duplicative prescriptions: One-month analysis of medical facilities in Japan. Health Policy 2016;120(3):334-41. https://doi.org/10.1016/j.healthpol.2016.01.020
  11. Lim CM, Aryani Md Yusof F, Selvarajah S, Lim TO. Use of ATC to describe duplicate medications in primary care prescriptions. Eur J Clin Pharmacol 2011;67(10):1035-44. https://doi.org/10.1007/s00228-011-1025-4
  12. Al Khaja KAJ, Ahmed Isa H, Veeramuthu S, Sequeira RP. Potentially inappropriate prescribing in older adults with hypertension or diabetes mellitus and hypertension in a primary care setting in Bahrain. Med Princ Pract 2018;27(3):241-9. https://doi.org/10.1159/000488055
  13. Sohn H-S, Lee Y-S, Choi K-E, Shin HT. Analysis of frequent therapeutic duplication drug classes based on national health insurance claimed data in Korea. Korean J Clin Pharm 2010;20(3):262-7.
  14. Kim J, Park S, Kim H, Je NK. National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus. Eur J Clin Pharmacol 2019;75(12):1723-30. https://doi.org/10.1007/s00228-019-02751-9
  15. Health insurance review & assessment service. Drug reimbursement list and table of upper limits. Available from https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA030014050000&brdScnBltNo=4&brdBltNo=1622&pageIndex=4. Accessed Oct 1, 2021.
  16. Choi HE, Lee JW, Je NK, Jeon KH. Use of SGLT2 inhibitor/metformin fixed dose combination in Korea. Korean J Clin Pharm 2022;32(1):13-9. https://doi.org/10.24304/kjcp.2022.32.1.13
  17. Shrestha PL, Shrestha PA, Vivo RP. Epidemiology of comorbidities in patients with hypertension. Curr Opin Cardiol 2016;31(4):376-80. https://doi.org/10.1097/HCO.0000000000000298
  18. Mohamed SF, Uthman OA, Caleyachetty R, et al. Uncontrolled hypertension among patients with comorbidities in sub-Saharan Africa: protocol for a systematic review and meta-analysis. Syst Rev 2020;9(1):1-5. https://doi.org/10.1186/s13643-019-1259-2
  19. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120(8):713-9. https://doi.org/10.1016/j.amjmed.2006.08.033
  20. Gottwald-Hostalek U, Sun N, Barho C, Barho C, Hildemann S. Management of hypertension with a fixed-dose (single-pill) combination of bisoprolol and amlodipine. Clin Pharmacol Drug Dev 2017;6(1):9-18. https://doi.org/10.1002/cpdd.309
  21. Bramley DE. The ability of anaesthetists to identify generic medications from trade names. Anaesth Intensive Care 2009;37(4):624-9. https://doi.org/10.1177/0310057X0903700401
  22. Aronson JK. Medication errors resulting from the confusion of drug names. Expert Opin Drug Saf 2004;3(3):167-72. https://doi.org/10.1517/eods.3.3.167.31069
  23. Korea Institute of Drug Safety & Risk Management. Therapeutic Duplication. Available from https://www.drugsafe.or.kr/iwt/ds/ko/useinfo/EgovDurInfoSerEff.do. Accessed May 15, 2022.
  24. Golchin N, Frank SH, Vince A, Isham L, Meropol SB. Polypharmacy in the elderly. J Res Pharm Pract 2015;4(2):85. https://doi.org/10.4103/2279-042X.155755
  25. Rambhade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A. A survey on polypharmacy and use of inappropriate medications. Toxicol Int 2012;19(1):68-73. https://doi.org/10.4103/0971-6580.94506
  26. Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc 2015;16(6):535.e1-12.
  27. Cooper JA, Moriarty F, Ryan C, et al. Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria. Eur J Clin Pharmacol. 2016;72(5):583-91. https://doi.org/10.1007/s00228-015-2003-z
  28. Salazar JA, Poon I, Nair M. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 2007;6(6):695-704. https://doi.org/10.1517/14740338.6.6.695
  29. Mason NA. Polypharmacy and medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens 2011;20(5):492-7. https://doi.org/10.1097/MNH.0b013e328349c261
  30. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013;158(11):825-30. https://doi.org/10.7326/0003-4819-158-11-201306040-00007
  31. Zaman ZA, Kumari V. Comparison of the effects of amlodipine and cilnidipine on blood pressure, heart rate, proteinuria and lipid profile in hypertensive patients. Int J Basic Clin Pharmacol 2013;2(2):160-4. https://doi.org/10.5455/2319-2003.ijbcp20130308
  32. Vrettos I, Voukelatou P, Katsoras A, Theotoka D, Kalliakmanis A. Diseases linked to polypharmacy in elderly patients. Curr Gerontol Geriatr Res 2017;2017:4276047.
  33. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021;42(36):3599-726. https://doi.org/10.1093/eurheartj/ehab368
  34. Lee I-H, Shim D-Y. Trends and appropriateness of outpatient prescription drug use in veterans. Korean J Clin Pharm 2018;28(2):107-16. https://doi.org/10.24304/kjcp.2018.28.2.107
  35. Health Insurance Review and Assessment Service. 2019 Drug reimbursement adequacy evaluation result. Available from https://www.hira.or.kr/cms/open/04/04/12/2020_9.pdf. Accessed May 15, 2022.
  36. Koo H, Lee MT, You SH, et al. Duplicated tramadol use in chronic low back pain: A nationwide cross-sectional study. Basic Clin Pharmacol Toxicol 2020;126(3):226-35. https://doi.org/10.1111/bcpt.13324
  37. Korean law information center. Criteria for Special Cases concerning the Calculation of Partial Burden of Self-Employee. Available from https://www.law.go.kr/LSW//admRulInfoP.do?admRulSeq=2100000207843&chrClsCd=010201#AJAX. Accessed May 15, 2022.
  38. Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010;10:16. https://doi.org/10.1186/1472-6904-10-16
  39. Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing 2005;34(6):626-32. https://doi.org/10.1093/ageing/afi202